Physician

Brett A. Trockman, M.D.

According to 2025 Medicare claims, Brett Trockman, M.D. (NPI: 1548279797) practices urology in the Elgin, IL market, with the plurality of this provider's patient population coming from Kane, IL. This provider's primary affiliated billing organization is UROPARTNERS, LLC (NPI: 1396790168; TIN: 20-1780406) and primary practice location at 60187-5576.

Trockman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 855 traditional Medicare patients, billed 15,159 HCPCS/CPT codes, and received $328,162 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,849 prescription claims across 645 beneficiaries totaling $1,490,259 in drug costs, led by Erleada (Apalutamide). DME data shows 130 claims. Open Payments data shows 31 records totaling $704. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $328,290 to $1,490,259. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $1,233 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	924	4,457	$252,437
2016	932	5,037	$268,728
2017	950	6,660	$282,528
2018	925	9,867	$279,112
2019	992	11,543	$332,873
2020	927	11,585	$299,369
2021	920	17,206	$370,953
2022	863	14,160	$361,091
2023	878	11,942	$356,713
2024	855	15,159	$328,162

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	463	2,061	$328,290
2016	517	2,376	$348,017
2017	537	2,499	$263,582
2018	550	2,432	$422,989
2019	559	2,465	$708,052
2020	581	2,535	$1,009,354
2021	608	2,584	$1,046,904
2022	601	2,476	$936,903
2023	604	2,559	$1,171,814
2024	645	2,849	$1,490,259

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	132	$40,217
2016	38	184	$58,740
2017	40	264	$66,595
2018	41	226	$80,079
2019	30	163	$84,354
2020	20	161	$83,776
2021	33	148	$92,007
2022	29	121	$99,527
2023	20	137	$102,874
2024	18	130	$102,818

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	399	699	$98
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	422	627	$69
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	642	1,165	$13
51798	Ultrasound measurement of bladder capacity after voiding	317	509	$9
81003	Automated urinalysis test	462	768	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Erleada	Apalutamide	57	1,710	$852,400
Myrbetriq	Mirabegron	268	17,343	$259,431
Orgovyx	Relugolix	38	1,136	$103,839
Gemtesa	Vibegron	102	5,580	$88,713
Mirabegron Er	Mirabegron	23	1,830	$19,239

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	45	$57,110
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	18	85	$45,708

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	29	$704	Dendreon Pharmaceuticals LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	2	$75,371	SN Holdings, LLC

Explore More Providers

FAQ

What Medicare data is available for Brett A. Trockman, M.D.?

Tedicare shows public-source Medicare data for Brett A. Trockman, M.D. (NPI 1548279797), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brett A. Trockman, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Brett A. Trockman, M.D.?

Brett A. Trockman, M.D. is linked to UROPARTNERS, LLC (billing NPI 1396790168) in the available physician profile data.

Does Brett A. Trockman, M.D. have Open Payments data?

Brett A. Trockman, M.D. has 31 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.